The stock of Tevogen Bio Holdings Inc (NASDAQ: TVGN) has decreased by -0.38 when compared to last closing price of 1.30. Despite this, the company has experienced a -3.36% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-30 that WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™.
Is It Worth Investing in Tevogen Bio Holdings Inc (NASDAQ: TVGN) Right Now?
Company’s 36-month beta value is -0.67.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TVGN is 26.87M, and currently, short sellers hold a 7.07% ratio of that floaft. The average trading volume of TVGN on June 05, 2025 was 881.39K shares.
TVGN’s Market Performance
The stock of Tevogen Bio Holdings Inc (TVGN) has seen a -3.36% decrease in the past week, with a 23.33% rise in the past month, and a 17.73% gain in the past quarter. The volatility ratio for the week is 2.25%, and the volatility levels for the past 30 days are at 3.45% for TVGN. The simple moving average for the last 20 days is 6.43% for TVGN stock, with a simple moving average of 13.81% for the last 200 days.
Analysts’ Opinion of TVGN
Many brokerage firms have already submitted their reports for TVGN stocks, with D. Boral Capital repeating the rating for TVGN by listing it as a “Buy.” The predicted price for TVGN in the upcoming period, according to D. Boral Capital is $10 based on the research report published on March 04, 2025 of the current year 2025.
TVGN Trading at 16.70% from the 50-Day Moving Average
After a stumble in the market that brought TVGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.09% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at TVGN starting from Flomenberg Neal, who sale 232,968 shares at the price of $1.09 back on Mar 12 ’25. After this action, Flomenberg Neal now owns 3,595,608 shares of Tevogen Bio Holdings Inc, valued at $253,935 using the latest closing price.
Flomenberg Neal, the See Remarks of Tevogen Bio Holdings Inc, sale 71,273 shares at $1.14 during a trade that took place back on Mar 07 ’25, which means that Flomenberg Neal is holding 3,969,212 shares at $81,251 based on the most recent closing price.
Stock Fundamentals for TVGN
Current profitability levels for the company are sitting at:
- -86.75 for the present operating margin
- 0.25 for the gross margin
The net margin for Tevogen Bio Holdings Inc stands at -89.16. The total capital return value is set at 7.4. Equity return is now at value -124.74, with -849.23 for asset returns.
Based on Tevogen Bio Holdings Inc (TVGN), the company’s capital structure generated -0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -7.21. The debt to equity ratio resting at -0.24. The interest coverage ratio of the stock is -9333.73.
Currently, EBITDA for the company is -53.56 million with net debt to EBITDA at 0.0. When we switch over and look at the enterprise to sales, we see a ratio of 625.6. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.35.
Conclusion
In a nutshell, Tevogen Bio Holdings Inc (TVGN) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
